Technical Data
A4150-03A
Atrial Natriuretic Peptide, pro-, aa1-28 (ANP, ANF, Atrial natriuretic factor, Atrial natriuretic factor precursor, CDD ANF, Natriuretic Peptide Precursor A, NPPA, PND, Prepronatriodilatin, Cardiodilatin-related peptide)
Description:
Applications:
Suitable for use in ELISA. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
MabIgG1L11-11-D6-B4 Affinity Purified
SizeStorageShippingSourceHost
10ug-20CBlue IceHumanMouse
Concentration:
~1mg/ml
Immunogen:
Synthetic peptide corresponding to aa1-28, SLRRSSCFGGRMDRFGAQSGLGCNSFRY of human pro-ANP.
Purity:
Purified by Protein G affinity chromatography.
Form
Supplied as a lyophilized powder. Reconstitute with sterile dH2O.
Specificity:
Recognizes synthetic human Atrial Natriuretic Peptide (aa 1-28).
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.